Product Name: Human Complement C5 Antibody (Tesidolumab, Research Use)
Catalog Number: NBR-0890
Target Name: Complement C5
Trade Name: Tesidolumab
Antibody Drug Description: Tesidolumab (LFG316) is a fully-human IgG1/λ anti-C5 monoclonal antibody of 143 kDa (without glycosylation), with a half-life in humans of approximately 9 days. Tesidolumab blocks cleavage of C5 and prevents subsequent formation of the membrane attack complex. Appearance: Transparent Liquid
Molecular Weight: ~150kDa
CAS：N/A
Solubility: Water; PBS, TBS Buffer etc.
Expression System: CHO Expressed
Isotype of Ab: Ab. Isotype - IgG

  Gene Name: C5
Synonyms: C5a; C5b; CPAMD4
Target Description: Activation of C5 by a C5 convertase initiates the spontaneous assembly of the late complement components, C5-C9, into the membrane attack complex. C5b has a transient binding site for C6. The C5b-C6 complex is the foundation upon which the lytic complex is assembled.
Ensembl: ENSG00000106804
Uniprot: P01031